Sepp-Lorenzino Laura 4
4 · Taysha Gene Therapies, Inc. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Sepp-Lorenzino Laura
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-02+113,246→ 113,246 totalExercise: $2.79Exp: 2035-06-02→ Common Stock (113,246 underlying) - Award
Common Stock
2025-06-02+56,623→ 105,843 total
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.